(Press-News.org) Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
"We ultimately envision this as a prognostic tool to predict survival rates for people with tobacco related cancers. Recognizing patients with high expression of these genes could help us predict risk and so match patients with the most appropriate treatments," says Garrett Dancik, PhD, postdoc in the lab of Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center.
The study mined data from publicly-available tumor registries that included a total of 1996 samples of cancer types including lung adenocarcinoma, squamous cell lung carcinoma, bladder transitional cell carcinoma, and head and neck squamous cell carcinoma. The question was this: what common genetic signatures would correlate with patient outcomes? Interestingly, researchers had previously asked this question of prostate cancer and had developed a panel of 31 cell-cycle related genes that predict the aggressiveness of the disease. Once Dancik and Theodorescu narrowed in on pathways controlling cell cycle as possibly predictive in tobacco-related cancers, they wondered if the same 31-gene panel might work with these cancers as well.
"Take out the squamous cell cancers and the panel is strongly predictive of patient outcomes," Dancik says. "This is a strong tool that could have a really useful application – only it seems there's something unique going on with the squamous cell types of tobacco-associated cancers that's not true for the others."
In Dancik's opinion, the discovery of correlation between cell cycle gene signatures and patient outcomes is an important first step in developing new ways to predict the risks of tobacco-associated cancers. The work now is in integrating this finding with existing risk assessments.
### END
AACR news: Misregulated genes common to tobacco-related cancers offer potential new prognostic tool
Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
AACR news: K9 osteosarcoma samples identify drivers of metastasis in pediatric bone cancer
2013-04-09
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year. Research from the University of Colorado Cancer Center and the Colorado State University Flint Animal Cancer Center presented at the AACR Annual Meeting 2013 used easily available K9 osteosarcoma samples to discover a novel protein that governs metastasis and chemoresistance in pediatric osteosarcoma.
"We have a pediatric osteosarcoma ...
AACR news: New target plus new drug equals death of melanoma cells
2013-04-09
Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer Research (AACR) Annual Conference, shows that the protein receptor Mer is overexpressed in melanoma and that the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them.
"It's exciting in that Mer receptor expression correlates so perfectly with disease progression. It's tiered – you see a bump in expression as you transition ...
AACR news: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
2013-04-09
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug ...
AACR news: Little molecule makes big difference in bladder cancer metastasis
2013-04-09
In order to kill, bladder cancer must metastasize, most commonly to the lung – what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a.
Messenger RNA or mRNA carries gene blueprints to sites where the plans are read and made into proteins, and to a large degree microRNA or miRNA tells mRNA what to do. Theodorescu's work shows that in 256 samples of ...
AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize
2013-04-09
In results presented at the AACR Annual Meeting 2013, researchers from the University of Colorado Cancer Center show that the Six2 homeoprotein, while not involved in primary tumor growth, allows cells to detach from substrate and survive their transition through the bloodstream to faraway sites of metastasis.
"Here we show for the first time that Six2 causes breast cancer progression. It's this metastasis, especially to the lung, that can eventually be deadly and so perhaps even more so than affecting the size of the primary tumor, we are especially excited to present ...
1-2 punch could be key in treating blindness
2013-04-09
EAST LANSING, Mich. — Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment could help restore vision in people, too.
Published in the journal Molecular Therapy, the study builds on earlier work by Michigan State University veterinary ophthalmologist András Komáromy and colleagues. In 2010, they restored day vision in dogs suffering from achromatopsia, an inherited form of total color blindness, by replacing the mutant ...
High pressure gold nanocrystal structure revealed
2013-04-09
A major breakthrough in measuring the structure of nanomaterials under extremely high pressure has been made by researchers at the London Centre for Nanotechnology (LCN).
Described in Nature Communications, the study used new advances in x-ray diffraction to image the changes in morphology of gold nanocrystals under pressures of up to 6.5 gigapascals.
Under high pressures, imaging methods such as electron or atomic force microscopy are not viable, making x-ray diffraction imaging the only option. However, until recently, focusing an image created with this method ...
Nanotechnology imaging breakthrough
2013-04-09
Washington, D.C.— A team of researchers has made a major breakthrough in measuring the structure of nanomaterials under extremely high pressures. For the first time, they developed a way to get around the severe distortions of high-energy X-ray beams that are used to image the structure of a gold nanocrystal. The technique, described in April 9, 2013, issue of Nature Communications, could lead to advancements of new nanomaterials created under high pressures and a greater understanding of what is happening in planetary interiors.
Lead author of the study, Wenge Yang ...
Dedicated cleaning staff shown to reduce C. difficile contamination in hospital rooms
2013-04-09
With rates and deaths associated with Clostridium difficile (C. difficile) at historically high levels, many hospitals have taken extra steps to reduce these infections. New research finds that a dedicated daily cleaning crew who adequately clean and disinfect rooms contaminated by C. difficile using a standardized process can be more effective than other disinfection interventions. The study is published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), in a special topic issue focused ...
Decontamination of unused medical supplies reduces health-care costs
2013-04-09
CHICAGO (April 9, 2013)– In rooms of patients with multidrug-resistant organisms (MDROs), the outside of the packages containing sterile items can become contaminated. Unused medical supplies are often thrown away to prevent the items from becoming pathways for transmission of drug-resistant microbes, and in the process this leads to increased healthcare costs. Researchers at Johns Hopkins Hospital found that hydrogen peroxide vapor (HPV) is an effective way to sanitize the outside of the packages of these sterile supplies.
In addition to protecting patients, use of ...
LAST 30 PRESS RELEASES:
New report outlines science priorities for human Mars exploration
Want to curb cannabis-related crashes? Don’t forget older adults, study finds
Expectant management vs medication for patent ductus arteriosus in preterm infants
Pew funds 7 new biomedical research collaborations
The ERC selects 349 mid-career researchers for €728 million in Consolidator Grants
ERC Consolidator Grant awarded to CISPA researcher Rayna Dimitrova
Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common peri-implantitis pathogens in vitro
EVs pose no greater risk to pedestrians than conventional vehicles
Modeling microplastic accumulation under the ocean surface
Pompeii offers insights into ancient Roman building technology
University of Utah engineers give a bionic hand a mind of its own
Transient and long-term risks of common physical activities in people with low back pain
Health care contact days in older adults with metastatic cancer
Brain resilience science reshapes psychiatry from treating illness to building strength
An assessment of the antidepressant potential of deramciclane in two animal tests
Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools
Brain discovery opens door to earlier detection of metabolic syndrome in women
SwRI-led study provides insight into oscillations in solar flares
Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research
GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk
Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease
Oyster larvae on drugs move slowly and are stressed
Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds
Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma
Improving treatment for an autoimmune bleeding condition
Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery
Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia
Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
Online tracking and privacy on hospital websites
A freely available tool to document wartime destruction
[Press-News.org] AACR news: Misregulated genes common to tobacco-related cancers offer potential new prognostic toolResults presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes